MedPacto, Inc. (KOSDAQ:235980)
South Korea · Delayed Price · Currency is KRW 2,850.00
+65.00 (2.33%)
Sep 1, 2026, 3:30 PM KST
MedPacto Market Cap
MedPacto has a market cap or net worth of 95.46 billion as of September 1, 2026. Its market cap has decreased by -31.23% in one year.
Market Cap
95.46B
Enterprise Value
61.45B
Revenue
4.99B
Ranking
n/a
PE Ratio
n/a
Stock Price
2,850.00
ChartMarket Cap Chart
Since December 19, 2019, MedPacto's market cap has decreased from 362.50B to 95.46B, a decrease of -73.67%. That is a compound annual growth rate of -18.05%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 31, 2026 | 95.46B | -58.31% |
| Dec 30, 2025 | 228.96B | 50.62% |
| Dec 30, 2024 | 152.01B | -37.48% |
| Dec 28, 2023 | 243.12B | -48.17% |
| Dec 29, 2022 | 469.05B | -60.97% |
| Dec 30, 2021 | 1.20T | -49.78% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 19, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Anterogen.Co.,Ltd. | 148.59B |
| GC Genome | 141.20B |
| Helixmith | 138.14B |
| Genexine | 124.39B |
| Vaxcell-Bio Therapeutics | 93.03B |
| iNtRON Biotechnology | 87.89B |
| Prestige BioPharma | 77.28B |
| Amicogen | 68.34B |